Through a comprehensive analysis of the pancreatic cystic fluid analysis, the role of the cystic fluid analysis is confirmed in terms of accurate diagnosis of pancreatic cysts, appropriate prediction of treatment response, and to select proper treatment indication through analytic results.
Study Type
OBSERVATIONAL
Enrollment
500
Seoul National University Hospital
Seoul, South Korea
RECRUITINGdiagnostic accuracy by cystic fluid analysis
diagnostic accuracy by cystic fluid analysis in comparison with pathologic diagnosis
Time frame: up to 5 years after cystic fluid analysis
Overall survival
overall survival until death
Time frame: up to 5 years after cystic fluid analysis or surgical resection
Disease free survival
Period till tumor recurrence after surgical resection or intervention
Time frame: up to 5 years after cystic fluid analysis or surgical resection
Malignant transformation rate
the prevalence of malignant transformation during follow-up period (percent)
Time frame: up to 5 years after cystic fluid analysis
Prediction for treatment response in case of surgical resected or EUS-guided ethanol ablated pancreatic cysts
evaluation of treatment response for surgery of EUS guided therapy according to RECIST criteria v1.1
Time frame: up to 5 years after cystic fluid analysis or EUS guided ablative therapy
Cytology of cystic fluid
result of cytology of cystic fluid
Time frame: within 2 months after study enrollment
Chemical profile of CEA in cystic fluid
level of CEA in cystic fluid
Time frame: within 2 months after study enrollment
Chemical profile of Amylase in cystic fluid
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
level of amylase in cystic fluid
Time frame: within 2 months after study enrollment
Chemical profile of glucose in cystic fluid
level of glucose in cystic fluid
Time frame: within 2 months after study enrollment
DNA mutation profile of cystic fluid
targeted NGS for KRAS, NRAS, CDKN2A, TP53, SMAD4, RNF43, PTEN, PIK3CA, VHL, Aneuploid
Time frame: within 2 months after study enrollment